BISMARCK, N.D. (KFYR) – Eliminating a novel virus might require a novel approach. Vaccine makers Moderna and Pfizer are using messenger RNA, or mRNA, to produce their vaccines.
This new technology has never before received regulatory approval.
If the mRNA vaccines make it to the general public, doctors say they will look indistinguishable from traditional vaccines.
However, they work in a different way. Instead of injecting a dead or weakened version of the virus into the patient’s body, doctors will be injecting the genetic information to produce the antigen, or antibodies, to fight the disease.
Companies are developing mRNA vaccines to combat coronavirus, and people seem to be on the fence about the new method.
“I honestly don’t know. I guess I would probably wait for a while and see how things go before I would get the vaccine,” said Dickinson Resident Darcy